Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate (Q46768564)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 October 2005

Language	Label	Description	Also known as
English	Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate	scientific article published on 19 October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

meglumine antimoniate

1 reference

based on heuristic

inferred from title

author name string

Ioannis Vouldoukis

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Sandrine Rougier

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Bernard Dugas

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Paco Pino

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Dominique Mazier

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Frédérique Woehrlé

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

publication date

19 October 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

Veterinary Parasitology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

135

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

137-146

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Topoisomerases in kinetoplastids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

The topoisomerases of protozoan parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Functional discrimination between interleukin 6 and interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Interleukin 6 is involved in interleukin 1-induced activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Inflammation, immunoregulation, and inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Immunization of dogs with a Leishmania infantum-derived vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Inhibitors of trypanosome topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Emergence of zoonotic canine leishmaniasis in the United States: isolation and immunohistochemical detection of Leishmania infantum from foxhounds from Virginia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Flow cytometric analysis of cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Canine leishmaniasis. A review based on 95 cases in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

Microscopic observation of progressive immobilization of leishmania promastigotes in acridine orange stain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient immunity against Leishmania major in the absence of interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2005.09.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VETPAR.2005.09.003

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16242844

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46768564&oldid=2130887509"